Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Onconetix Q3 EPS $(6.25) Up From $(249.05) YoY, Sales $303.651K Down From $406.859K YoY

Author: Benzinga Newsdesk | November 13, 2025 05:29pm
Onconetix (NASDAQ:ONCO) reported quarterly losses of $(6.25) per share. This is a 97.49 percent increase over losses of $(249.05) per share from the same period last year. The company reported $303.651 thousand in sales this quarter. This is a 25.37 percent decrease over sales of $406.859 thousand the same period last year.

Posted In: ONCO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist